Giant cell arteritis and PMR
Giant cell arteritis, polymyalgia rheumatica and steroid-sparing treatment.
Key point
In PMR, interleukin-6 receptor blockers should be considered with glucocorticoids for relapsing disease and can be considered for new-onset high-risk patients.
From: Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica (Rheumatology (Oxford), 2026 Feb 4) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 13, 16, 15, 20, 23.
New guidelines and consensus this year
- Utility of the SCVP consensus statement of temporal artery biopsy for arteritisCardiovasc Pathol2026 Nov-Dec
- The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumaticaRheumatology (Oxford)2026 Oct 1
- French recommendations for the use of imaging in giant cell arteritisJoint Bone Spine2026 Oct
- Joint position paper on anterior ischemic optic neuropathy (AION). Vascular Risk Group and Systemic Autoimmune Diseases Group (GEAS) of the Spanish Society of Internal Medicine (SEMI) together with the Spanish Retina and Vitreous Society (SERV)Rev Clin Esp (Barc)2026 Sep 8
- Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritisClin Exp Rheumatol2026 Apr
All papers from the last 12 months
627 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Diagnostic pitfall: NSAID-induced membranous nephropathy with PLA2R positivity, IgG1-predominant deposits, C1q positivity, and concurrent acute interstitial nephritis-A case reportClin Chim Acta2027 Feb 15PMID 42503368
- Causal associations between antibody-mediated immune responses to infectious agents and cardiovascular inflammatory diseases: A Mendelian randomization study based on UK Biobank and FinnGenHum Vaccin Immunother2026 DecPMID 42284210
- Neurosurgical Manifestations of Rheumatologic Diseases: Clinical, Imaging, and Surgical ImplicationsRheum Dis Clin North Am2026 NovPMID 42849992Review
- Imaging in Rheumatic Diseases of the Head and NeckRheum Dis Clin North Am2026 NovPMID 42849985Review
- Cerebrovascular involvement in Erdheim-Chester disease: a case report and systematic literature reviewJ Clin Neurosci2026 NovPMID 42497572Systematic review
- Utility of the SCVP consensus statement of temporal artery biopsy for arteritisCardiovasc Pathol2026 Nov-DecPMID 42480884
- Rare vasculitis types and obstetric and neonatal outcomes - A population-based studyInt J Gynaecol Obstet2026 NovPMID 42223974
- Exploring gut microbiome dysbiosis in vasculitis in adults: a systematic reviewSyst Rev2026 Oct 17PMID 42888447Systematic review
- (18)F-Fluorodeoxyglucose PET in Rheumatologic and Autoimmune DisordersPET Clin2026 Oct 15PMID 42881037Review
- Jaw Claudication Progressing to Scalp and Tongue Necrosis in Giant Cell ArteritisJ Rheumatol2026 Oct 15PMID 42880893
More rheumatology trends
All specialties →Rheumatic immune-related adverse events
Arthritis, myositis and other rheumatic side effects of checkpoint inhibitors.
Ultrasound in rheumatology
Musculoskeletal and vascular ultrasound for diagnosis and monitoring.
Lung disease in systemic sclerosis
Interstitial lung disease in systemic sclerosis.
Psoriatic arthritis
Psoriatic arthritis and its targeted treatments.
JAK inhibitors in rheumatoid arthritis
JAK inhibitors in RA, including their safety.
Gout
Gout management, including treat-to-target urate lowering.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"giant cell arteritis"[tiab] OR "polymyalgia rheumatica"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.